^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CD123 targeted CAR-NK

    i
    Other names: CD123 targeted CAR-NK
    Associations

    News

    Trials
    Company:
    Chongqing Precision Biotech
    Drug class:
    NK cell stimulant, CD123 inhibitor
    Related drugs:
    Associations

    News

    Trials
    1m
    Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN (clinicaltrials.gov)
    P1, N=30, Recruiting, Chongqing Precision Biotech Co., Ltd
    New P1 trial
    |
    CD123 targeted CAR-NK
    over1year
    Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm (clinicaltrials.gov)
    P1/2, N=36, Recruiting, Chongqing Precision Biotech Co., Ltd
    New P1/2 trial
    |
    IL6 (Interleukin 6) • CD123 (Interleukin 3 Receptor Subunit Alpha) • IL3RA (Interleukin 3 Receptor Subunit Alpha)
    |
    CD123 positive • CD123 expression • IL3RA positive
    |
    cyclophosphamide • CD123 targeted CAR-NK